357 related articles for article (PubMed ID: 38505993)
1. Complement in the pathogenesis of Alzheimer's disease.
Morgan BP
Semin Immunopathol; 2018 Jan; 40(1):113-124. PubMed ID: 29134267
[TBL] [Abstract][Full Text] [Related]
2. The complement system in neurodegenerative diseases.
Nimmo J; Byrne RAJ; Daskoulidou N; Watkins LM; Carpanini SM; Zelek WM; Morgan BP
Clin Sci (Lond); 2024 Mar; 138(6):387-412. PubMed ID: 38505993
[TBL] [Abstract][Full Text] [Related]
3. Constitutively active STING causes neuroinflammation and degeneration of dopaminergic neurons in mice.
Szego EM; Malz L; Bernhardt N; Rösen-Wolff A; Falkenburger BH; Luksch H
Elife; 2022 Oct; 11():. PubMed ID: 36314770
[TBL] [Abstract][Full Text] [Related]
4. Neurodegenerative Disorders of Alzheimer, Parkinsonism, Amyotrophic Lateral Sclerosis and Multiple Sclerosis: An Early Diagnostic Approach for Precision Treatment.
Pathak N; Vimal SK; Tandon I; Agrawal L; Hongyi C; Bhattacharyya S
Metab Brain Dis; 2022 Jan; 37(1):67-104. PubMed ID: 34719771
[TBL] [Abstract][Full Text] [Related]
5. Inflammasome assembly in neurodegenerative diseases.
Singh J; Habean ML; Panicker N
Trends Neurosci; 2023 Oct; 46(10):814-831. PubMed ID: 37633753
[TBL] [Abstract][Full Text] [Related]
6. Role of complement in neurodegeneration and neuroinflammation.
Bonifati DM; Kishore U
Mol Immunol; 2007 Feb; 44(5):999-1010. PubMed ID: 16698083
[TBL] [Abstract][Full Text] [Related]
7. The role of complement in neurological and neuropsychiatric diseases.
Morgan BP
Expert Rev Clin Immunol; 2015; 11(10):1109-19. PubMed ID: 26389851
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease-associated complement gene variants influence plasma complement protein levels.
Veteleanu A; Stevenson-Hoare J; Keat S; Daskoulidou N; Zetterberg H; Heslegrave A; Escott-Price V; Williams J; Sims R; Zelek WM; Carpanini SM; Morgan BP
J Neuroinflammation; 2023 Jul; 20(1):169. PubMed ID: 37480051
[TBL] [Abstract][Full Text] [Related]
9. Complement C1q drives microglia-dependent synaptic loss and cognitive impairments in a mouse model of lipopolysaccharide-induced neuroinflammation.
Wu X; Gao Y; Shi C; Tong J; Ma D; Shen J; Yang J; Ji M
Neuropharmacology; 2023 Oct; 237():109646. PubMed ID: 37356797
[TBL] [Abstract][Full Text] [Related]
10. Complement C3a receptor antagonist alleviates tau pathology and ameliorates cognitive deficits in P301S mice.
Yao Y; Chang Y; Li S; Zhu J; Wu Y; Jiang X; Li L; Liu R; Ma R; Li G
Brain Res Bull; 2023 Aug; 200():110685. PubMed ID: 37330021
[TBL] [Abstract][Full Text] [Related]
11. Complement C3aR depletion reverses HIF-1α-induced metabolic impairment and enhances microglial response to Aβ pathology.
Gedam M; Comerota MM; Propson NE; Chen T; Jin F; Wang MC; Zheng H
J Clin Invest; 2023 Jun; 133(12):. PubMed ID: 37317973
[TBL] [Abstract][Full Text] [Related]
12. Quantitative proteomic profiling of white matter in cases of cerebral amyloid angiopathy reveals upregulation of extracellular matrix proteins and clusterin.
Manousopoulou A; Yuen HM; Sharp MM; Saito S; Aldea R; Mazer N; Garbis SD; Carare RO
Free Neuropathol; 2020 Jan; 1():. PubMed ID: 37283687
[No Abstract] [Full Text] [Related]
13. Complement C3 Enhances LPS-Elicited Neuroinflammation and Neurodegeneration Via the Mac1/NOX2 Pathway.
Zhou R; Chen SH; Zhao Z; Tu D; Song S; Wang Y; Wang Q; Feng J; Hong JS
Mol Neurobiol; 2023 Sep; 60(9):5167-5183. PubMed ID: 37268807
[TBL] [Abstract][Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
